About
About COVID States
Learn about the project →
People
Meet the consortium →
Learning
Hands-on training→
Publications
Reports
Read all of our reports →
Journal Publications
Read selected project papers →
Topics
Children and Youth
Explore this topic →
Economic Impact
Explore this topic →
Election
Explore this topic →
Executive Approval
Explore this topic →
Health Behavior
Explore this topic →
Mental Health
Explore this topic →
Misinformation
Explore this topic →
Policy Preferences
Explore this topic →
Schools
Explore this topic →
Testing
Explore this topic →
Vaccination
Explore this topic →
Other
Explore this topic →
Browse by Tag →
Data
Behaviors during COVID
View the tracker →
COVID-19 Tweets
View the tracker→
Trust in Institutions
View the tracker→
Vaccination Rates
View the tracker→
Views on Abortion
View the tracker→
Media Coverage
News articles
View selected media coverage →
Journalist resources
Inquiries →
Insights

Join Mailing ListContact Us
Home
About
About COVID States
Learn about the project →
People
Meet the consortium →
Publications
Reports
Read all of our reports →
Journal Publications
Read selected project papers →
Topics
Children and Youth
Explore this topic →
Economic Impact
Explore this topic →
Election
Explore this topic →
Executive Approval
Explore this topic →
Health Behavior
Explore this topic →
Mental Health
Explore this topic →
Misinformation
Explore this topic →
Policy Preferences
Explore this topic →
Schools
Explore this topic →
Testing
Explore this topic →
Vaccination
Explore this topic →
Other
Explore this topic →
Data
Behaviors During COVID
View the dashboard→
COVID-19 Tweets
View the dashboard→
Trust in Institutions
View the dashboard→
Vaccination Rates
View the dashboard→
Media Coverage
News articles
View selected news coverage →
Journalist resources
Inquiries→
Insights

Report #

90

Utilization Rates of Antivirals for COVID-19

By the COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States

Home
/
Publications
/
Reports
/
Utilization Rates of Antivirals for COVID-19

Key takeaways

While Paxlovid has been available since December 22, 2021, there have been challenges in its clinical application. Of people infected with COVID-19 between May and early July, only 11% report having taken antivirals.

Featured media Coverage

August 24, 2022

COVID Antivirals Like Paxlovid ‘Vastly Underused' During Pandemic, Study Says

NBC News

Tags




Report details

Published:
August
2022
Report Number:
90
Topic:
Other
OSF Preprint:
View  
Download report   

Related Reports

Report #
97
January
2023
Twitter, Social Media, and Elon Musk
Other

Report #
94
November
2022
American Attitudes Towards Russia’s Invasion Of Ukraine
Other

Report #
92
October
2022
The Mar-A-Lago Search
Other

Report #
89
July
2022
The Dobbs Decision, Support for Abortion, and 2022 Voting
Other

Join our mailing list to receive updates about new reports, findings, and datasets!
Join Mailing List
A multi-university collaboration
About
About COVID States
People
Learning
Insights
Publications
Reports
Journal Publications
Topics
Children and Youth
Economic Impact
Election
Executive Approval
Health Behavior
Mental Health
Misinformation
Policy Preferences
Schools
Testing
Vaccination
Other
Data
Behaviors during COVID
COVID-19 Tweets
Trust in Institutions
Vaccination Rates
Views on Abortion
Media
News articles
Journalist resources
© 2022  The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States
Contact us